China's NMPA approves Milestone's etripamil nasal spray for PSVTSep 3Regulatory decisionetripamilMilestone Pharmaceuticals Inc.
Milestone activates sites for Phase 3 AFib-RVR trial, reports $170.6M cashAug 12Quarterly updateetripamilMilestone Pharmaceuticals Inc.
Sign inSign in